Skip to content

An evaluation of the clinical and cost-effectiveness of pulmonary artery flotation catheters (PAC-Man) in intensive care.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN04539889
Enrollment
1041
Registered
2003-04-25
Start date
2000-01-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart disease Circulatory System Heart disease

Interventions

Patients in adult ICUs who are managed using PAC vs those who are not.

Sponsors

Department of Health (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All intensive care admissions, including high risk surgical patients.

Exclusion criteria

Exclusion criteria: Not provided at time of registration.

Design outcomes

Primary

MeasureTime frame
Hospital mortality, defined as death before discharge from hospital, incorporating death before discharge from ICU. There are no secondary outcome measures unless otherwise indicated by results of the systematic review. Economic Evaluation: The costs of care will be estimated using a top-down method. Cost-effectiveness ratios will be estimated for each outcome. Appropriate incremental cost-effectiveness ratios will also be calculated and sensitivity analysis around the cost and outcome of care will be undertaken.

Secondary

MeasureTime frame
Not provided at time of registration.

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026